Literature DB >> 7537514

Thrombelastography reveals two causes of haemorrhage in HELLP syndrome.

R K Whitta1, D J Cox, S V Mallett.   

Abstract

We describe the use of thrombelastography in HELLP syndrome (Haemolysis, Elevated Liver Enzymes, Low Platelets). It differentiated between two possible causes of significant haemorrhage and revealed an accompanying underlying fibrinolysis. This allowed specific therapy to be directed at both abnormalities and, we believe, helped prevent this patient from undergoing radical surgery to curb blood loss.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537514     DOI: 10.1093/bja/74.4.464

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  6 in total

1.  Thrombelastography Should Be Included in the Algorithm for the Management of Postpartum Hemorrhage.

Authors:  Csilla Jámbor; Sybille A Kozek-Langenecker; Thomas Frietsch; Ralf Knels
Journal:  Transfus Med Hemother       Date:  2008-09-16       Impact factor: 3.747

Review 2.  [Anesthesiological approach to postpartum hemorrhage].

Authors:  J Knapp; S Hofer; H Lier
Journal:  Anaesthesist       Date:  2016-03       Impact factor: 1.041

3.  Presentation of laboratory and sonoclot variables using principal component analysis: identification of hypo- and hypercoagulation in the HELLP syndrome.

Authors:  John J Liszka-Hackzell; Ulf Schött
Journal:  J Clin Monit Comput       Date:  2004-08       Impact factor: 2.502

4.  Disseminated intravascular coagulation complicating HELLP syndrome: perioperative management.

Authors:  Rakesh Garg; M P Nath; A P Bhalla; Ashwani Kumar
Journal:  BMJ Case Rep       Date:  2009-04-17

Review 5.  [Hemorrhaging during pregnancy].

Authors:  S Hofer; R Schreckenberger; B Heindl; K Görlinger; H Lier; H Maul; E Martin; M A Weigand
Journal:  Anaesthesist       Date:  2007-10       Impact factor: 1.041

Review 6.  Haemostatic monitoring during postpartum haemorrhage and implications for management.

Authors:  C Solomon; R E Collis; P W Collins
Journal:  Br J Anaesth       Date:  2012-10-16       Impact factor: 9.166

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.